Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study
BNT162b2 mRNA COVID-19 백신에 대한 항체 반응의 역학: 7개월 추적 연구
Article
[키워드] (Abbott
Abbott
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
All study participants
amplitude
anti-spike protein IgG
antibodies
antibody
Antibody Response
BNT162b2
BNT162b2 mRNA
BNT162b2 mRNA COVID-19 vaccine
BNT162b2 mRNA vaccine
booster dose
CMIA
Complete
comprehension
conducted
coronavirus
COVID-19
COVID-19 vaccine
division
Dynamics
Follow-up
healthcare
Healthcare workers
IgG
immune response
immune responses
Immunity
immunoassay
individual
individuals
infected individual
infected with SARS-CoV-2
Infection
Ireland
material
median
median titer
Microparticle
MONITOR
participant
Participants
reported
respiratory
response
Romania
SARS-CoV-2
SARS-CoV-2 IgG II Quant assay
second dose
sensitivity
Seven
severe acute respiratory syndrome Coronavirus
significantly higher
Sligo
specificity
Spike protein
study participant
subject
the antibody response
the median
the SARS-CoV-2
the vaccine
two groups
uninfected
vaccinated individual
vaccination
Vaccine
[DOI] 10.3390/medicina57121330 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/medicina57121330 PMC 바로가기 [Article Type] Article